Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Eastern Maine Medical Center
mi
from
Bangor, ME
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Illinois CancerCare - Canton
mi
from
Canton, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Billings Clinic-Cody
mi
from
Cody, WY
Click here to add this to my saved trials
Hematology Clinical Trial
HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hematology Clinical Trial
HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Trial Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Cervical Spondylotic Myelopathy Clinical Trial
Postural Stability in Cervical Spinal Myelopathy
Status: Enrolling, Phase
Updated: 12/31/1969
Syracuse VA Medical Center, Syracuse, NY
mi
from
Syracuse, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Post-Marketing Observational Study of VYXEOS™
Status: Enrolling, Phase
Updated: 12/31/1969
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Kootenai Medical Center
mi
from
Coeur d'Alene, ID
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Decatur Memorial Hospital
mi
from
Decatur, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Benefis Healthcare- Sletten Cancer Institute
mi
from
Great Falls, MT
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Illinois CancerCare - Macomb
mi
from
Macomb, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Idaho Urologic Institute - Meridian
mi
from
Meridian, ID
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Illinois CancerCare-Ottawa Clinic
mi
from
Ottawa, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Methodist Medical Center of Illinois
mi
from
Peoria, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Kootenai Cancer Center
mi
from
Post Falls, ID
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Springfield Clinic
mi
from
Springfield, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Missouri Baptist Sullivan Hospital
mi
from
Sullivan, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Cancer Care Specialists of Illinois-Swansea
mi
from
Swansea, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Minnesota Oncology and Hematology PA-Woodbury
mi
from
Woodbury, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Metro Health Hospital
mi
from
Wyoming, MI
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Hematology Clinical Trial
IMG-7289 in Patients With Myelofibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hematology Clinical Trial
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma
Status: Enrolling
Updated: 12/31/1969
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Cabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Graft-Versus-Host-Disease Clinical Trial
Natural History and Pathophysiology of Gastrointestinal Graft-versus-Host Disease
Status: Upcoming
Updated: 12/19/2012
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Robotic-Assisted Surgery in Treating Patients With Spine Tumors
Status: Upcoming
Updated: 6/1/2012
City of Hope National Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Langerhans Cell Histiocytosis Clinical Trial
Clofarabine for Langerhans in Pedi
Status: Upcoming, Phase II
Updated: 7/9/2014
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Myeloma Clinical Trial
Carfilzomib/SAHA Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant in Myeloma
Status: Upcoming, Phase II
Updated: 4/14/2014
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat
Status: Upcoming, Phase I, II
Updated: 4/3/2017
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
CD16/IL-15/CD33 Tri-Specific Killer Engagers (TriKEs) for High Risk Heme Malignancies
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Masonic Cancer Center at University of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Minnelide in Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Upcoming, Phase I
Updated: 11/15/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Evomela Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation (AutoSCT) for Multiple Myeloma (MM)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Fabry Disease Clinical Trial
Evaluation of Phenotypic Variability in Fabry Disease
Status: Upcoming, Phase
Updated: 12/31/1969
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Dendritic Cell DKK1 Vaccine for Monoclonal Gammopathy and Stable or Smoldering Myeloma
Status: Upcoming, Phase
Updated: 12/31/1969
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
Status: Upcoming, Phase
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Daratumumab Plus Ibrutinib in Patients With Waldenstrӧm's Macroglobulinemia
Status: Upcoming, Phase II
Updated: 12/31/1969
Weill Cornell Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors
Status: Upcoming, Phase II
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Safety and Efficacy of ABI-009 (Nab-rapamycin) in Combination With Pomalidomide and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Status: Upcoming, Phase I
Updated: 12/31/1969
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Daratumumab, Carfilzomib, Lenalidomide and Low Dose Dexamethasone (DKRd) in Newly Diagnosed, Multiple Myeloma
Status: Upcoming, Phase II
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Bone Marrow Disease Clinical Trial
A Clinical Trial of CK0801 (a New Drug) in Patients With Bone Marrow Failure Syndrome (BMF)
Status: Upcoming, Phase I
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Clinical Trial
Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Children's Hospital Colorado Center for Cancer and Blood Disorders
mi
from
Aurora, CO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
Status: Upcoming, Phase I
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Status: Upcoming, Phase II
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Status: Upcoming, Phase II
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology Clinical Trial
CS1-CAR T Therapy Following Chemotherapy in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Upcoming, Phase I
Updated: 12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
Status: Upcoming, Phase I
Updated: 12/31/1969
University of Chicago Medicine Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
PRGN-3006 Adoptive Cellular Therapy Relapsed or Refractory CD33-Positive AML or High Risk MDS
Status: Upcoming, Phase I
Updated: 12/31/1969
H. Lee Moffitt Cancer Center & Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
Amyloid Cardiomyopathy, Transthyretin-Related Clinical Trial
Screening for Cardiac Amyloidosis Using Nuclear Imaging for Minority Populations
Status: Upcoming, Phase
Updated: 12/31/1969
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming, Phase II
Updated: 12/31/1969
Millennium Oncology
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming, Phase II
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Heparin-Induced Thrombocytopenia Clinical Trial
Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)
Status: Upcoming
Updated: 7/24/2009
MedStar Washington Hospital Center
mi
from
Washington DC,
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Genetically Modified Peripheral Blood Stem Cell Transplant in Treating Patients With HIV-Associated Non-Hodgkin or Hodgkin Lymphoma
Status: Upcoming
Updated: 12/15/2014
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Lymphocyte Profiles and Activation Status in Patients With Graft-Versus-Host Disease
Status: Upcoming
Updated: 11/14/2013
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma
Status: Upcoming, Phase II
Updated: 3/23/2016
Waverly Hematology
mi
from
Cary, NC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma
Status: Upcoming, Phase II
Updated: 3/23/2016
James R. Berenson, MD, Inc
mi
from
West Hollywood, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Midostaurin in Treating Older Patients With Mutated Acute Myeloid Leukemia Post-Transplant
Status: Upcoming, Phase II
Updated: 3/27/2018
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Wee1 Kinase Inhibitor AZD1775 and Combination Chemotherapy in Treating Children, Adolescents and Young Adults With Relapsed or Refractory Acute Myeloid Leukemia
Status: Upcoming, Phase I
Updated: 6/13/2016
COG Phase I Consortium
mi
from
Arcadia, CA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
Status: Upcoming, Phase II
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Congenital Adrenal Hyperplasia Clinical Trial
Androgen Reduction in Congenital Adrenal Hyperplasia
Status: Upcoming, Phase II
Updated: 12/31/1969
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Congenital Adrenal Hyperplasia Clinical Trial
Androgen Reduction in Congenital Adrenal Hyperplasia
Status: Upcoming, Phase II
Updated: 12/31/1969
National Institutes of Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Recurrent Plasma Cell Myeloma Clinical Trial
Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant
Status: Upcoming, Phase II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
High Dose Ascorbic Acid for Plasma Cell Disorders
Status: Upcoming, Phase I
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Hematology Clinical Trial
Pembrolizumab in Treating Participants With Leukoplakia
Status: Upcoming, Phase II
Updated: 12/31/1969
UC San Diego Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
211At-BC8-B10 and Donor Stem Cell Transplant in Treating Relapsed or Refractory AML, ALL, or Myelodysplastic Syndrome
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia
Status: Upcoming, Phase I
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Enasidenib as Maintenance Therapy in Treating Patients With Acute Myeloid Leukemia With IDH2 Mutation After Donor Stem Cell Transplant
Status: Upcoming, Phase I
Updated: 12/31/1969
Moffitt Cancer Center
mi
from
Tampa, FL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Clinical Trial
Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Clinical Trial
Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Nicklaus Children's Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Acute Graft-versus-Host Disease Clinical Trial
Safety and Efficacy of Itacitinib in Combination With Corticosteroids for Treatment of Graft-Versus-Host Disease in Pediatric Subjects
Status: Upcoming, Phase I, II
Updated: 12/31/1969
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Beth Israel Deaconess
mi
from
Boston, MA
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
The Ohio State University College of Medicine
mi
from
Columbus, OH
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
U.T. Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer
Status: Upcoming, Phase II
Updated: 12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Status: Upcoming, Phase I
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
CPX-351 and Enasidenib in Treating Patients With Relapsed Acute Myeloid Leukemia Characterized by IDH2 Mutation
Status: Upcoming, Phase II
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Unrelated Donor Blood and Marrow Transplantation
Status: Upcoming, Phase I, II
Updated: 12/31/1969
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Status: Upcoming, Phase I, II
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Enasidenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia With an IDH2 Gene Mutation
Status: Upcoming, Phase II
Updated: 12/31/1969
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bortezomib, Dexamethasone, and Cyclophosphamide in Treating Older Patients With Multiple Myeloma
Status: Upcoming, Phase II
Updated: 10/23/2014
University Hospitals Case Medical Center, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Langerhans Cell Histiocytosis Clinical Trial
Clofarabine for Langerhans in Pedi
Status: Upcoming, Phase II
Updated: 7/9/2014
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Severe Hemophilia A Clinical Trial
Hemophilia Inhibitor Prevention and Eradication Clinical Trials (INHIBIT) Platform
Status: Upcoming, Phase III
Updated: 12/31/1969
Hemophilia Center of Western Pennsylvania
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Hu8F4 in Treating Patients With Advanced Hematologic Malignancies
Status: Upcoming, Phase I
Updated: 12/31/1969
M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Comparative Study of Ceftazidime-Avibactam Versus Standard of Care as Therapy in Febrile Neutropenic Adults With Cancer
Status: Upcoming, Phase II
Updated: 4/4/2016
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Benign Prostatic Hyperplasia Clinical Trial
Analysis of Prostatic Arterial Embolization for Benign Prostatic Hyperplasia Using Embosphere Microspheres
Status: Upcoming
Updated: 2/5/2016
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Status: Upcoming, Phase II
Updated: 12/31/1969
Rutgers Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Hematology Clinical Trial
Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma
Status: Upcoming, Phase II
Updated: 12/31/1969
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Status: Upcoming, Phase II
Updated: 12/31/1969
Fred Hutch/University of Washington Cancer Consortium
mi
from
Seattle, WA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Carfilzomib, Lenalidomide, and Dexamethasone Versus Bortezomib, Lenalidomide and Dexamethasone (KRd vs. VRd) in Patients With Newly Diagnosed Multiple Myeloma (COBRA)
Status: Upcoming, Phase III
Updated: 12/31/1969
University of Chicago Medicine Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Relapsed Refractory Multiple Myeloma Clinical Trial
Myeloma-Developing Regimens Using Genomics (MyDRUG)
Status: Upcoming, Phase I, II
Updated: 12/31/1969
Mayo Clinic Minnesota
mi
from
Rochester, MN
Click here to add this to my saved trials
1 … 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 … 121